the aid library

LIST OPTIONS

Filter

5337

Information note on HIV and COVID-19

World Health Organization WHO (2020) C_WHO

People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega... more

COVID-19 and HIV: Moment, Epidemics, Opportunities

UNAIDS (2020) C_WHO

The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.

Download (228)

View PDF (270)

Therapeutics and COVID-19: living guideline, Updated 16 September 2022
recommended

World Health Organization WHO (2022) C_WHO

This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi... more

Download (159)

View PDF (180)

Ethical considerations in HIV prevention trials

World Health Organization WHO; UNAIDS (2021) C_WHO

UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio... more

Download (443)

View PDF (192)

Neonatal Care Clinical Guidelines

UNICEF, World Health Organisation (WHO) (2018) CC

This first edition of our national neonatal care clinical guidelines is an initiative that aims to ensure that all the neonates in the Kingdom of Eswatini are offered standard, best quality of care and the best possible start in life. The guidelines have been formulated from various global sources a... more

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Final Report

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download (137)

View PDF (291)

Cervical Cancer in Women with HIV in Latin America and the Caribbean: Update and Steps Towards Elimination

PAHO, ICW-LATINA PAHO (2020) C_WHO

This fact sheet is based on a systematic review of the literature on HPV and cervical cancer epidemiology, and a survey on policies and practices related to the prevention and control of cervical cancer among women living with HIV (WLHIV) to PAHO Member States. It details scorecards on the advances ... more

External Link

JOIN European First Aid Guidelines
recommended

Johanniter International (2022) C2

In the event of an accident or medical emergency, First Aid saves lives. Keeping the patient alive and safe until the arrival of expert professional help is a vital part of the chain of care which leads to recovery. The principle of First Aid must be simple skills, clearly taught and capable of bein... more

External Link

African Union Health Information Exchange Guidelines and Standards

Africa Center for Disease Control and Prevention (2023) CC

The application of digital health technology is growing at a rapid rate in Africa, with the goals of improving the delivery of healthcare services and more effectively reaching out to remote and underserved communities. The lack of enabling guidelines and standards across the continent, on the other... more

Download (286)

View PDF (247)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (286)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Medicines for HIV, viral hepatitis and sexually transmitted infections in low- and middle- income countries: forecasts of global demand for 2022–2026

World Health Organization WHO (2024) C_WHO

For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries. The purpose of this rep... more

The missing link: Rethinking and reprioritizing HIV and gender-based violence in fragile settings

UNAIDS (2024) CC

This report explores the extent to which evidence, policy, normative guidance and commitments on HIV and gender-based violence, and their interlinkages, is being translated into action on the ground in fragile settings. These issues are explored through the lens of training of peace support operatio... more

Kenya Asthma Management Guideline

Ministry of Health (2021) CC

Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid... more

Download (382)

View PDF (428)

The Role of Women's Empowerment in Influencing HIV Testing

Bashemera, Domitilla R., Martha J. Nhembo, and Grace Benedict ICF International (2013) C2

DHS Working Papers No. 101 Women’s empowerment, HIV testing, birth in past five years, Tanzania

External Link

Association between HIV status and depressive symptoms among children and adolescents in the Southern Highlands Zone, Tanzania: A case-control study

A. Lwidiko; S. M. Kibusi; A. Nyundo; et al. PLOS One (2018) CC

PLOS ONE | https://doi.org/10.1371/journal.pone.0193145 February 22, 2018 1 / 13

Download (261)

View PDF (530)

Regional Response Plan for TB-HIV 2017-2021

World Health Organization (South-East Asia) World Health Organization (South-East Asia) (2017) C_WHO

Download (131)

View PDF (303)

Training manual for law enforcement officials on HIV service provision for people who inject drugs

D. Riley; N. Thomson; G. Monaghan; et al. United Nations Office for Drugs and Crime (UNODC) (2020) C2

Advance Copy Accessed: 08.03.2020

Download (163)

View PDF (200)

Research and Evaluation Agenda for HIV and Maternal Health in sub-Saharan Africa

Kendall, Tamil; Danel, Isabella (2014) C1

Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp... more

Download (120)

View PDF (163)

Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave

B. C. Zanoni; M. Archary; S. Buchan; I. T. Katz; J. E. Haberer BMJ Global Health; Pub Med (2016) C2

Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004

Therapeutics and COVID-19: living guideline, Updated 16 September 2022 recommended

JOIN European First Aid Guidelines recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Therapeutics and COVID-19: living guideline, Updated 16 September 2022
recommended

JOIN European First Aid Guidelines
recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended